125 related articles for article (PubMed ID: 17763178)
1. Nutritional status of hemodialysis patients with hepatitis C infection.
Chong VH
Ren Fail; 2007; 29(6):773. PubMed ID: 17763178
[No Abstract] [Full Text] [Related]
2. Prevalence and seroconversion to HCV in hemodialyzed patients, and epidemiological factors.
Morales MF; Lossi JS; Alderete TN; Noli D
Transplant Proc; 1996 Dec; 28(6):3402-5. PubMed ID: 8962329
[No Abstract] [Full Text] [Related]
3. Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features.
Stefanidis I; Liakopoulos V; Rigopoulou EI; Dalekos GN
Am J Kidney Dis; 2005 Nov; 46(5):992-3; author reply 993. PubMed ID: 16253745
[No Abstract] [Full Text] [Related]
4. The effect of anti-HCV seropositivity on the TNF-alpha level in hemodialysis patients.
Sengil AZ; Gürbilek M; Altindiş M; Uysal H; Koşar A; Baysal B
Clin Nephrol; 1995 Jul; 44(1):69-70. PubMed ID: 7554537
[No Abstract] [Full Text] [Related]
5. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML
J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
8. Assessment of peripheral DNA damage by alkaline comet assay in maintenance hemodialysis subjects with hepatitis C infection.
Horoz M; Bolukbas C; Bolukbas FF; Kocyigit A; Aslan M; Koylu AO; Gumus M; Celik H; Koksal M
Mutat Res; 2006 Apr; 596(1-2):137-42. PubMed ID: 16458331
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in patients on hemodialysis and after renal transplantation in the area of Rijeka-Croatia.
Brncić N; Vujaklija-Stipanović K; Crnić-Martinović M; Matić-Glazar D
Transplant Proc; 1996 Feb; 28(1):178. PubMed ID: 8644166
[No Abstract] [Full Text] [Related]
10. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients.
Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L
Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548
[TBL] [Abstract][Full Text] [Related]
11. Effect of hepatitis C infection on anemia in hemodialysis patients.
Khurana A; Nickel AE; Narayanan M; Foulks CJ
Hemodial Int; 2008 Jan; 12(1):94-9. PubMed ID: 18271849
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection and the dialysis patient.
Fabrizi F; Lunghi G; Ganeshan SV; Martin P; Messa P
Semin Dial; 2007; 20(5):416-22. PubMed ID: 17897248
[TBL] [Abstract][Full Text] [Related]
13. Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report.
Tarwater K; Misra S; Misra M
Hemodial Int; 2008 Oct; 12 Suppl 2():S38-42. PubMed ID: 18837769
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to hepatitis C virus in patients with chronic renal disease in Sri Lanka.
Fernando S; Fernando SS; Sheriff MH; Vitarana UT
Transplant Proc; 2002 Dec; 34(8):3087-90. PubMed ID: 12493383
[No Abstract] [Full Text] [Related]
15. Nutritional supplementation in adult patients on hemodialysis.
Cano N
J Ren Nutr; 2007 Jan; 17(1):103-5. PubMed ID: 17198944
[TBL] [Abstract][Full Text] [Related]
16. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients.
Chiu YL; Chen HY; Chuang YF; Hsu SP; Lai CF; Pai MF; Yang SY; Peng YS
Nephrol Dial Transplant; 2008 Nov; 23(11):3685-9. PubMed ID: 18515654
[TBL] [Abstract][Full Text] [Related]
17. Low seroconversion rates in CAPD patients compared to hemodialysis patients: potential advantages for transplant candidates.
Akpolat T; Dilek M; Yavuz M; Utas C; Ozener C; Karayaylali I; Yilmaz E; Ersoy F; Camsari T; Ataman R; Bozfakioglu S; Akcicek F; Ates K; Arinsoy T;
Perit Dial Int; 2002; 22(4):520-3. PubMed ID: 12322827
[No Abstract] [Full Text] [Related]
18. Biochemical nutritional parameters and their impact on hemodialysis efficiency.
Abbas HN; Rabbani MA; Safdar N; Murtaza G; Maria Q; Ahamd A
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1105-9. PubMed ID: 19861885
[TBL] [Abstract][Full Text] [Related]
19. Management of hepatitis B and C in renal failure and renal transplant recipients.
Amarapurkar D; Das HS
Trop Gastroenterol; 2002; 23(2):49-53. PubMed ID: 12632966
[No Abstract] [Full Text] [Related]
20. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
